Abstract
The first malignant tumor of the paranasal sinuses was removed with curative intent in Slovenia in 1991. After that, 24 more patients with malignant tumors of the paranasal sinuses were treated with endoscopic surgery until 2007. The surgery for malignant tumors of the head and neck is done in 2 centers only, with a multidisciplinary approach. The second stage in development of the endoscopic surgery began in 2005 when duraplasty became routine and also more extensive surgery, including anterior transnasal craniectomy, was possible. The histology of the tumors is diverse: 8 patients had sinonasal squamous cell carcinoma, 7 adenocarcinoma NOS, 4 malignant melanomas, 2 olfactory neuroblastomas, 2 leiomyosarcomas, and 1 chondrosarcoma. The median follow-up was 69 months. Radical resection was possible in 23 out of 24 patients. In the patient with microscopic remnant, local recurrence developed after 2.5 years; after 2 surgeries the patient is alive without disease. Of the 24 patients, 20 (86%) are alive with NED; 2 (8.3%) died from distant metastases, and 2 died from other causes. All patients with R0 resection remained free of disease locally. The question arises whether endoscopic surgery for malignant tumors is feasible even in a country with a small population (2 million inhabitants) and incidence of only 17 new cases per year in 2005. Therefore, we employed a teaching, diagnostic, and therapeutic protocol to maximize results and avoid mistreatment of the patients: consistent use of updated technology, multi-institutional team approach with sharing of experiences, and concentration of the cases in the 2 tertiary centers. We placed technical, theoretical, and practical knowledge of duraplasty as the mainstay of contemporary management of the tumors of the nose and sinuses, and we used our “know-how” of conventional/classical oncologic surgery. We also emphasize that endoscopes and microscopes are only tools for achieving the best results, that is, minimal morbidity and radical oncologic surgery.